(Q46766015)

25 December 2017

title

L-NAME- and ADMA-induced sympathetic neural activation in conscious rats (English)

1 reference

25 December 2017

author name string

Robert A Augustyniak

1

1 reference

25 December 2017

Ronald G Victor

2

1 reference

25 December 2017

Donald A Morgan

3

1 reference

25 December 2017

Weiguo Zhang

4

1 reference

25 December 2017

publication date

20 October 2005

1 reference

25 December 2017

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

25 December 2017

volume

290

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

R726-32

1 reference

25 December 2017

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Nitric oxide pathway as new drug targets for refractory hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Responses of rat postganglionic sympathetic vasoconstrictor neurons following blockade of nitric oxide synthesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

The L-arginine-nitric oxide pathway in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Aortic Distensibility and Structural Changes in Sinoaortic-Denervated Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N(omega)-nitro-L-arginine methyl ester.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Histochemical mapping of nitric oxide synthase in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Neuronal nitric oxide reduces sympathetic excitability by modulation of central glutamate effects in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00768.2004

10.1152/AJPREGU.00768.2004

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017